期刊文献+

人乳头状瘤病毒16型E6基因短发夹结构RNA慢病毒载体的构建及鉴定

Construction and Identification of Short Hairpin RNA Lentiviral Vector of Human Papillomavirus(HPV) 16 E6
下载PDF
导出
摘要 目的以人乳头瘤病毒(human papillomavirus,HPV)16型E6基因为靶点,构建小发夹状RNA(small hairpin RNA,shRNA)慢病毒载体.方法将HPV 16E6基因的特异性序列,应用基因重组技术插入到包含U6启动子及绿色荧光蛋白(GFP)报告基因的慢病毒载体pGCL-GFP中.重组质粒命名为pGCL-GFP-HPV16-E,测序鉴定后与慢病毒包装质粒pHelper 1.0及pHelper 2.0通过lipofectamine 2000共转染293T细胞,病毒液根据绿色荧光蛋白(GFP)表达水平测定滴度.结果 PCR扩增和测序结果证实HPV16 E6 shRNA核苷酸链序列插入正确,包装慢病毒产生病毒悬液,测定滴度为2×109 TU/mL.结论应用基因重组技术等方法,可成功构建HPV16 E6 shRNA慢病毒载体. Objective To establish a lentiviral vector-mediated RNA interference(RNAi)of Human Papillomavirus(HPV)16 E6 gene.Methods Using genetic recombination technology,a pair of complementary small hairpin RNA(shRNA)oligonucleotides targeting the HPV16 E6 gene was cloned into lentiviral expression vector pGCL-GFP,which contained U6 promoter and green fluorescent protein reporter.The recombined plasmid named pGCL-GFP-vshHPV 16 E6 was confirmed by polymerase chain reaction and sequencing,and was cotransfected with pHel per 1.0 and pHel per 2.0 packaging plasmids into 293T cells by lipofectamine 2000;the lentivirus titer was determined according to the expression level of green fluorescent protein(GFP).Results PCR and DNA sequencing demonstrated that the inserted sequences were correct.The titer of virus was 2E+9 TU /ml.Conclusion A lentiviral shRNA expression vector targeting the HPV16 E6 gene is successfully constructed.
出处 《昆明医学院学报》 2011年第3期16-20,共5页 Journal of Kunming Medical College
基金 广东省自然科学基金资助项目(07005147)
关键词 人乳头瘤病毒 小发夹状RNA E6 慢病毒 Human papillomavirus Short hairpin RNA E6 Lentivirus
  • 相关文献

参考文献11

  • 1RAMPIAST,SASAKIC,WEINBERGERP,et al.E6 and E7 gene silencing and transformed phenotype of human papillomavirus 16 positive propharyngeal cancer cells[J].Natl Cancer Inst,2009,101 (6):412-423.
  • 2PARKIN D M,BRAY F I,DEVESA S S,et al.Cancer burden in the year 2000.The global picture[J].Eur J Cancer,2001,37(Suppl8):S4.
  • 3NAIR S,PILLAI M R.Human papillomavirus and disease mechanisms:relevance to oral and cervical cancers[J].Oral Dis,2005,11 (6):350-359.
  • 4SCHEURER M E,TORTOLERO-LUNA G,ADLER-STORTHZ K,et al.Human papillomavirus infection:biology,epidemiology,and prevention[J].Int J Gynecol Cancer,2005,15 (5):727-746.
  • 5ELBASHIR S M,HARBOETH J,LENDECKLW,et al.Dup lexes of 212 nucleo-tide RNAs mediate RNA interference in cultured mammalian cells[J].Nature,2001,411 (6836):494.
  • 6PADDISON P J.RNA interference in mammalian cell systems[J].Curr Top Microbiol I mmunol,2008,320:1-19.
  • 7RANGASAMY D,TREMETHICK D J,GREAVES I K,et al.Gene knockdown by ecdysone-based inducible RNAi in stable mammalian cell lines[J].Nat Protoc,2008,3(1):79-88.
  • 8VLASSOV A V,KORBA B,FARRAR K,et al.shRNAs targeting hepatitis C:effects of sequence and structural features,and comparision with siRNA[J].Oligonucleotides,2007,17 (2):223-236.
  • 9REYNOLDSA,LEAKEDD,BOSES Q,et al.Rational siRNA design for RNA interference[J].Nat Biotechnol,2004,22 (3):326-330.
  • 10NESCHADIM A,MCCART J A,KEATING A,et al.A roadmap to safe,efficient,and stable lentivirusmediated gene therapy with hematopoietic cell transplantation[J].Biol Blood Marrow Transplant,2007,13 (12):1407-1416.

二级参考文献9

  • 1Sugimoto K, Honda S, Yamamoto T, et al. Molecular cloning and characterization of a newly identified member of the cadherin family, PB-cadherin [ J ]. J Biol Chem, 1996, 271 : 11548-56.
  • 2Patel SD, Chen CP, Bahna F, et al. Cadherin-mediated cell-cell adhesion: sticking together as a family [J ]. Curr Opin Struct Biol, 2003, 13: 690-8.
  • 3Bauer R, Bosserhoff AK. Functional implication of truncated P- cadherin expression in malignant melanoma [J ]. Exp Mol Pathol, 2006, 81: 224-30.
  • 4Tomita K, van Bokhoven A, van Leenders G J, et al. Cadherin switching in human prostate cancer progression[J]. Cancer Res, 2000, 60: 3650-4.
  • 5Munoz-Guerra MF, Marazuela EG, Femandez-Contreras ME, et al. P-cadherin expression reduced in squamous cell carcinoma of the oral cavity: an indicatior of poor prognosis [ J ]. Cancer, 2005, 103: 960-9.
  • 6Taniuchi K, Nakagawa H, Hosokawa M, et al. Overexpressed P- cadherin/CDH3 promotes motility of pancreatic cancer cells by interacting with p120ctn and activating rho-family GTPases [J]. Cancer Res, 2005, 65: 3092-9.
  • 7Kim JS, Han J, Shim YM, et al. Aberrant methylation of H-cadherin (CDH13) promoter is associated with tumor progression in primary nonsmall cell lung carcinoma[ J ]. Cancer, 2005, 104:1825-33.
  • 8Bonilla C, Mason T, Long L, et al. E-cadherin polymorphisms and haplotypes influence risk for prostate cancer [J ]. Prostate, 2006, 66: 546-56.
  • 9Charalabopoulos K, Gogali A, Dalavaga Y, et al. The clinical significance of soluble E-cadherin in nonsmall cell lung cancer [J ]. Exp Oncol, 2006, 28:83-5.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部